RCKT - Rocket Pharmaceuticals, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

RCKT is currently covered by 7 analysts with average potential upside of $25.34 (130.23%) backed by 24 price targets and 44 ratings. Documented since 27-Nov-2018. Analyst's average stock valuation to be materialised ratio is 27.72% with an average time for price targets to be met of 105.89 days.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 01-Mar-2023.

Highest price target for RCKT is 45, Lowest price target is 9, average price target is 27.

Currently, out of the existing stock ratings of RCKT - 24 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

63

$46.33 (277.92%)

65

26 days ago

4/11 (36.36%)

$30.7 (211.35%)

107

Buy

60

$43.33 (259.93%)

60

27 days ago

0/5 (0%)

$41.66 (300.09%)

Buy

35

$18.33 (109.96%)

34

3 months 4 days ago

1/2 (50%)

$14.51 (74.26%)

145

Buy

33

$16.33 (97.96%)

34

4 months 20 days ago

1/4 (25%)

$12.09 (75.62%)

159

Buy

75

$56.4 (303.23%)

65

5 months 25 days ago

0/5 (0%)

$53.32 (190.35%)

Show more analysts

What is RCKT(Rocket Pharmaceuticals, Inc) average time for price targets to be met?

On average it took 105.89 days on average for the stock forecasts to be realized with a an average price target met ratio 27.72

Which analyst has the current highest performing score on RCKT(Rocket Pharmaceuticals, Inc) with a proven track record?

TYLER VAN BUREN